HRT FINANCIAL LP

Position in XNCR — Xencor Inc

CIK 1475597 NEW YORK, NY

Position in XNCR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,201,301

+$481,235 QoQ

Shares Held

74,615

+25.0% QoQ

Ownership

0.100%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#68

of 208 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $848,581,551 across 184 Biotechnology names. XNCR ranks #63 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	1,089,376	$81,136,724
2	INSM	INSMED Inc	689,981	$73,565,774
3	EXEL	Exelixis, Inc.	929,242	$50,560,057
4	MDGL	Madrigal Pharmaceuticals, Inc.	84,634	$45,444,226
5	AXSM	Axsome Therapeutics, Inc.	178,491	$43,689,242
6	ARWR	Arrowhead Pharmaceuticals, Inc.	498,655	$40,645,369
7	ABVX	Abivax S.A.	270,612	$36,061,755
8	TGTX	Tg Therapeutics, Inc.	622,603	$34,205,808

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,201,301	74,615	+25.0%	Shares	Defined	2026-08-14
2026-03-31	$720,066	59,707	-51.9%	Shares	Defined	2026-05-14
2025-09-30	$1,455,258	124,063	+99.5%	Shares	Defined	2025-11-14
2024-09-30	$1,250,640	62,190	+190.3%	Shares	Defined	2024-11-12
2023-12-31	$454,767	21,421	-27.0%	Shares	Defined	2024-02-09
2023-09-30	$591,442	29,352	+7.3%	Shares	Defined	2023-11-13
2022-12-31	$712,610	27,366	+21.3%	Shares	Defined	2023-02-10
2022-09-30	$586,160	22,562	+15.2%	Shares	Defined	2022-11-14
2022-03-31	$522,661	19,590	+6.9%	Shares	Defined	2022-05-16
2021-12-31	$734,918	18,318	-36.5%	Shares	Defined	2022-02-14
2021-09-30	$941,424	28,825	-25.3%	Shares	Defined	2021-11-15
2021-06-30	$1,330,279	38,570	+158.0%	Shares	Defined	2021-08-16
2021-03-31	$643,833	14,952	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.